Glucagon stimulates gluconeogenesis by INSP3R1-mediated hepatic lipolysis-Reference-Cited by-同舟云学术

Glucagon stimulates gluconeogenesis by INSP3R1-mediated hepatic lipolysis

Published:2020-03-04 Issue:7798 Volume:579 Page:279-283
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

Perry Rachel J.,Zhang Dongyan,Guerra Mateus T.^ORCID,Brill Allison L.^ORCID,Goedeke Leigh,Nasiri Ali R.,Rabin-Court Aviva,Wang Yongliang,Peng Liang,Dufour Sylvie,Zhang Ye,Zhang Xian-Man,Butrico Gina M.,Toussaint Keshia,Nozaki Yuichi,Cline Gary W.,Petersen Kitt Falk,Nathanson Michael H.,Ehrlich Barbara E.^ORCID,Shulman Gerald I.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41586-020-2074-6.pdf

Reference35 articles.

1. Unger, R. H. Glucoregulatory hormones in health and disease. A teleologic model. Diabetes15, 500–506 (1966).

2. Unger, R. H. Pancreatic glucagon in health and disease. Adv. Intern. Med. 17, 265–288 (1971).

3. Müller, T. D., Finan, B., Clemmensen, C., DiMarchi, R. D. & Tschöp, M. H. The new biology and pharmacology of glucagon. Physiol. Rev. 97, 721–766 (2017).

4. Brand, C. L. et al. Immunoneutralization of endogenous glucagon with monoclonal glucagon antibody normalizes hyperglycaemia in moderately streptozotocin-diabetic rats. Diabetologia37, 985–993 (1994).

5. Sørensen, H. et al. Immunoneutralization of endogenous glucagon reduces hepatic glucose output and improves long-term glycemic control in diabetic ob/ob mice. Diabetes55, 2843–2848 (2006).

Cited by 128 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Piperlongumine, a natural alkaloid from Piper longum L. ameliorates metabolic-associated fatty liver disease by antagonizing the thromboxane A2 receptor;Biochemical Pharmacology;2024-11

2. NCLX controls hepatic mitochondrial Ca2+ extrusion and couples hormone-mediated mitochondrial Ca2+ oscillations with gluconeogenesis;Molecular Metabolism;2024-09

3. Asperuloside Activates Hepatic NRF2 Signaling to Stimulate Mitochondrial Metabolism and Restore Lipid Homeostasis in High Fat Diet-Induced MAFLD;European Journal of Pharmacology;2024-09

4. Obesity and MASLD: Is weight loss the (only) key to treat metabolic liver disease?;Metabolism;2024-08

5. Glucagon promotes increased hepatic mitochondrial oxidation and pyruvate carboxylase flux in humans with fatty liver disease;Cell Metabolism;2024-08